Gene · 7272
Papers3,094
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 3,094
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prognostic model of hepatocellular carcinoma based on cancer grade. | World J Clin Cases | 2023 | 37900243 | PubTator, text mining | PubMed |
| Unlocking the Potential of the CA2, CA7, and ITM2C Gene Signatures for the Early Detection of Colorectal Cancer: A Comprehensive Analysis of RNA-Seq Data by Utilizing Machine Learning Algorithms. | Genes (Basel) | 2023 | 37895185 | PubTator, text mining | PubMed |
| CWH43 Is a Novel Tumor Suppressor Gene with Negative Regulation of TTK in Colorectal Cancer. | Int J Mol Sci | 2023 | 37894942 | PubTator, text mining | PubMed |
| PLK1 promotes the mitotic surveillance pathway by controlling cytosolic 53BP1 availability. | EMBO Rep | 2023 | 37888778 | PubTator, text mining | PubMed |
| Exploring Plant Meiosis: Insights from the Kinetochore Perspective. | Curr Issues Mol Biol | 2023 | 37886947 | PubTator, text mining | PubMed |
| Permission to pass: on the role of p53 as a gatekeeper for aneuploidy. | Chromosome Res | 2023 | 37864038 | PubTator, text mining | PubMed |
| Plasmodium falciparum Genetic Diversity and Resistance Genotype Profile in Infected Placental Samples Collected After Delivery in Ouagadougou. | Infect Drug Resist | 2023 | 37849789 | PubTator, text mining | PubMed |
| Molecular landscape and functional characterization of centrosome amplification in ovarian cancer. | Nat Commun | 2023 | 37845213 | PubTator, text mining | PubMed |
| Transcriptomic subtyping of malignant peripheral nerve sheath tumours highlights immune signatures, genomic profiles, patient survival and therapeutic targets. | EBioMedicine | 2023 | 37837931 | PubTator, text mining | PubMed |
| Proteomic and Phosphoproteomic Reprogramming in Epithelial Ovarian Cancer Metastasis. | Mol Cell Proteomics | 2023 | 37820923 | PubTator, text mining | PubMed |
| TTK is a potential regulator of tumor progression correlated with dedifferentiation and immune cell infiltration in papillary thyroid cancer. | Aging (Albany NY) | 2023 | 37815894 | PubTator, text mining | PubMed |
| Breast cancer stem cells tolerate chromosomal instability during tumor progression via c-Jun/AXL stress signaling. | Heliyon | 2023 | 37809421 | PubTator, text mining | PubMed |
| Exploring factors influencing the uptake of kangaroo mother care: key informant interviews with parents. | BMC Pregnancy Childbirth | 2023 | 37789260 | PubTator, text mining | PubMed |
| A clinically useful and biologically informative genomic classifier for papillary thyroid cancer. | Front Endocrinol (Lausanne) | 2023 | 37772080 | PubTator, text mining | PubMed |
| Therapeutic targeting of the TPX2/TTK network in colorectal cancer. | Cell Commun Signal | 2023 | 37770979 | PubTator, text mining | PubMed |
| Disclosing transcriptomics network-based signatures of glioma heterogeneity using sparse methods. | BioData Min | 2023 | 37752578 | PubTator, text mining | PubMed |
| Estimating disease-free survival of thyroid cancer based on novel cuprotosis-related gene model. | Front Endocrinol (Lausanne) | 2023 | 37745716 | PubTator, text mining | PubMed |
| A novel marker integrating multiple genetic alterations better predicts platinum sensitivity in ovarian cancer than HRD score. | Front Genet | 2023 | 37732324 | PubTator, text mining | PubMed |
| Long non-coding RNA AC099850.4 correlates with advanced disease state and predicts worse prognosis in triple-negative breast cancer. | Front Med (Lausanne) | 2023 | 37727755 | PubTator, text mining | PubMed |
| Disentangling the roles of aneuploidy, chromosomal instability and tumour heterogeneity in developing resistance to cancer therapies. | Chromosome Res | 2023 | 37721639 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7272/papers?page=15